NCT07264959 2026-04-22
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Blueprint Medicines Corporation
Recruiting
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Fondazione IRCCS Policlinico San Matteo di Pavia